Tuesday, October 8, 2024

HomeHealth NewsCRISPR-Cas9 Editing Can Favor Cancer-Linked KRAS Genes - Clinical OMICs News

CRISPR-Cas9 Editing Can Favor Cancer-Linked KRAS Genes – Clinical OMICs News

- Advertisement -

Highlighting the need to monitor patients who have undergone CRISPR-Cas9-based gene therapy for cancer-related mutations, researchers at Sanford Burnham Prebys have shown that gene editing, specifically gene knockout (KO) using CRISPR-Cas9 technology, can…

Click here to view the original article.

- Advertisment -

Recently Viewed